Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Oncology Institute Inc. (TOIIW:NASDAQ), powered by AI.
The Oncology Institute Inc. is currently trading at $0.04. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for The Oncology Institute Inc. on Alpha Lenz.
View The Oncology Institute Inc.'s valuation metrics on Alpha Lenz.
“The Oncology Institute Inc.'s ROE is 999.2%. Explore profitability and growth together.”
Ask for details →The Oncology Institute Inc. is a healthcare service provider focused on delivering comprehensive, community-based cancer care. The primary function of this company is to ensure accessible and personalized oncology treatment, aiming to improve patient outcomes through a multidisciplinary approach. The Institute specializes in various oncology disciplines, providing services, including chemotherapy management, radiation therapy, clinical trials, and palliative care. Its operations are instrumental in serving a growing patient population with cutting-edge treatment solutions and enhancing oncological research advancements. The role of The Oncology Institute in the financial market is significant due to its potential in addressing the rising demand for cancer treatment in the healthcare sector. By implementing an integrated care model, it impacts both national healthcare policies and local patient communities, aiming to expand access to high-quality cancer care across various geographical regions.
“The Oncology Institute Inc.'s ROE is 999.2%. Explore profitability and growth together.”
Ask for details →The Oncology Institute Inc. (ticker: TOIIW) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 825 employees.
The current price is $0.043 with a P/E ratio of -x and P/B of -x.
ROE is 999.19% and operating margin is -7.18%. Annual revenue is $503M.